| Home use of an artificial beta cell in type 1 diabetes H Thabit, M Tauschmann, JM Allen, L Leelarathna, S Hartnell, ... New England Journal of Medicine 373 (22), 2129-2140, 2015 | 523 | 2015 |
| Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial M Tauschmann, H Thabit, L Bally, JM Allen, S Hartnell, ME Wilinska, ... The Lancet 392 (10155), 1321-1329, 2018 | 440 | 2018 |
| Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2× 2 factorial randomized controlled trial comparing insulin pump with multiple daily … SA Little, L Leelarathna, E Walkinshaw, HK Tan, O Chapple, ... Diabetes care 37 (8), 2114-2122, 2014 | 276 | 2014 |
| Consensus recommendations for the use of automated insulin delivery technologies in clinical practice M Phillip, R Nimri, RM Bergenstal, K Barnard-Kelly, T Danne, R Hovorka, ... Endocrine reviews 44 (2), 254-280, 2023 | 265 | 2023 |
| Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial R Hovorka, D Elleri, H Thabit, JM Allen, L Leelarathna, R El-Khairi, ... Diabetes care 37 (5), 1204-1211, 2014 | 251 | 2014 |
| Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European … O Moser, MC Riddell, ML Eckstein, P Adolfsson, R Rabasa-Lhoret, ... Diabetologia 63 (12), 2501-2520, 2020 | 248 | 2020 |
| Flash forward: a review of flash glucose monitoring L Leelarathna, EG Wilmot Diabetic Medicine 35 (4), 472-482, 2018 | 214 | 2018 |
| Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial D Elleri, JM Allen, K Kumareswaran, L Leelarathna, M Nodale, K Caldwell, ... Diabetes care 36 (4), 838-844, 2013 | 194 | 2013 |
| Patients’ and caregivers’ experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study J Lawton, M Blackburn, J Allen, F Campbell, D Elleri, L Leelarathna, ... BMC endocrine disorders 18, 1-10, 2018 | 188 | 2018 |
| Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study H Thabit, A Lubina-Solomon, M Stadler, L Leelarathna, E Walkinshaw, ... The lancet Diabetes & endocrinology 2 (9), 701-709, 2014 | 186 | 2014 |
| Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents KD Barnard, T Wysocki, JM Allen, D Elleri, H Thabit, L Leelarathna, ... BMJ Open Diabetes Research and Care 2 (1), e000025, 2014 | 175 | 2014 |
| A glycemia risk index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings DC Klonoff, J Wang, D Rodbard, MA Kohn, C Li, D Liepmann, D Kerr, ... Journal of diabetes science and technology 17 (5), 1226-1242, 2023 | 174 | 2023 |
| Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study L Leelarathna, S Dellweg, JK Mader, JM Allen, C Benesch, W Doll, ... Diabetes Care 37 (7), 1931-1937, 2014 | 160 | 2014 |
| Hybrid closed‐loop therapy: where are we in 2021? L Leelarathna, P Choudhary, EG Wilmot, A Lumb, T Street, P Kar, SM Ng Diabetes, Obesity and Metabolism 23 (3), 655-660, 2021 | 139 | 2021 |
| Closing the loop in adults, children and adolescents with suboptimally controlled type 1 diabetes under free living conditions: a psychosocial substudy KD Barnard, T Wysocki, V Ully, JK Mader, TR Pieber, H Thabit, ... Journal of diabetes science and technology 11 (6), 1080-1088, 2017 | 132 | 2017 |
| Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial L Leelarathna, SW English, H Thabit, K Caldwell, JM Allen, ... Critical Care 17, 1-12, 2013 | 132 | 2013 |
| Five-year follow-up of a cohort of people with their first diabetic foot ulcer: the persistent effect of depression on mortality K Winkley, H Sallis, D Kariyawasam, LH Leelarathna, T Chalder, ... Diabetologia 55, 303-310, 2012 | 129 | 2012 |
| Intermittently scanned continuous glucose monitoring for type 1 diabetes L Leelarathna, ML Evans, S Neupane, G Rayman, S Lumley, I Cranston, ... New England Journal of Medicine 387 (16), 1477-1487, 2022 | 128 | 2022 |
| Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial E Bosi, P Choudhary, HW De Valk, S Lablanche, J Castañeda, S De Portu, ... The lancet Diabetes & endocrinology 7 (6), 462-472, 2019 | 123 | 2019 |
| Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK MJ Carr, AK Wright, L Leelarathna, H Thabit, N Milne, N Kanumilli, ... The Lancet. Diabetes & Endocrinology 9 (7), 413, 2021 | 112 | 2021 |
